Novartis to present pivotal data in hematologic and solid tumor cancers at 2016 ASCO Annual Meeting
• First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna®both in front-line and second-line ...
• First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna®both in front-line and second-line ...
GlaxoSmithKline and Innoviva, Inc announced results from data presented at the American Thoracic Society (ATS) 2016 International Conference investigating the ...
Pfizer announced results from the second phase of its global RA surveys, which assessed the relationship between physician-patient communication and ...
• Ho Chi Minh City Communities for Healthy Hearts Program is the second innovative healthcare model for hypertension ...
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety ...
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, ...
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, ...
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the ...
• Detects biomarkers of horse infection, inflammation, immune response and general health • Addresses unmet needs of equine research ...
fizer Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) approved ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.